Find News

Filter articles

Applied Filters

Showing 21 to 30 of 847 results

LSPN Europe: new challenges for drug patent owners in Russia

Russia21-11-2019Rory O'Neill

Russian drug patent owners are being forced to come up with novel solutions to combat generic manufacturers trying to clear the way for competitor medicines.

Drop prices or lose patent rights, say White House hopefuls

US21-11-2019Rory O'Neill

US presidential candidates Bernie Sanders and Cory Booker have tabled a bill that would force drug companies to adhere to government-set prices-or risk losing patent exclusivity.

Russian government approves compulsory drug licensing bill

Russia19-11-2019Rory O'Neill

The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.

Chinese state-owned chemical firm in fungicide patent suit

China, US14-11-2019Rory O'Neill

A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.

Novartis acquires Japanese generics business in €400m deal

Japan12-11-2019Rory O'Neill

Novartis has agreed to buy the Japanese business of South African generics manufacturer Aspen Pharmacare for a potential €400 million.

Pfizer and Sun settle Bosulif dispute

06-11-2019Rory O'Neill

Pfizer and Indian drugmaker Sun Pharmaceuticals have agreed to settle patent litigation over a generic version of Pfizer’s leukaemia drug, Bosulif.

Takeda sells generics portfolio to Stada for $660m

Germany, Russia06-11-2019Saman Javed

German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.

Global Drug Facility adds new TB drug to its catalogue

India, US31-10-2019Saman Javed

The Global Drug Facility, which provides tuberculosis treatments to those in need in 150 countries, has listed a new drug to its product catalogue.

Allergan pays $750m to resolve antitrust litigation

US29-10-2019Sarah Morgan

Allergan has reached a $750 million deal to resolve antitrust litigation brought against its subsidiary Forest Laboratories over Alzheimer’s drug Namenda.

Novartis takes aim at Indian drug companies over Entresto generics

India, US29-10-2019Rory O'Neill

Swiss pharmaceutical company Novartis has filed a patent infringement lawsuit against three Indian rivals in a US federal court over proposed generics of its heart failure drug Entresto.

Showing 21 to 30 of 847 results